| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |